ArticleCureus2026
Lacosamide-Responsive Paroxysmal Tonic Spasms Associated With a New Lateral Cerebral Peduncle Lesion in Multiple Sclerosis: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paroxysmal tonic spasms (PTS) are abrupt, brief, involuntary, and often painful muscle contractions commonly seen in demyelinating disorders such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). These movements are frequently associated with new demyelinating lesions in the corticospinal tract. First-line treatment is usually carbamazepine, a sodium channel blocker, but intolerance and side effects may limit its use. We report a case of a 31-year-old woman with clinically stable relapsing-remitting MS who developed sudden, painful spasms of the left upper limb. MRI of the brain showed a new lesion in the lateral part of the right cerebral peduncle, consistent with her symptoms. She was first started on carbamazepine, which was discontinued due to gastrointestinal side effects. Lacosamide, another antiepileptic with a similar mechanism of action, was introduced at a dose of 50 mg twice daily, resulting in rapid and complete resolution of her symptoms. During follow-up, the patient remained symptom-free and clinically stable. This case highlights the occurrence of PTS secondary to a lateral cerebral peduncle lesion. Lacosamide was highly effective in controlling symptoms, suggesting it is a good alternative for patients who cannot tolerate carbamazepine. Awareness of PTS and timely imaging can guide adequate therapy and improve patients' quality of life. Lacosamide may represent an effective and well-tolerated alternative when first-line therapy cannot be used.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.